No Structure Information
This entry has no structure information.
To add it, be sure the Wikipedia entry contains a valid CAS number in its "Chembox", "Chembox new", "Drugbox", or "Explosivebox" template.
Even with a valid CAS number, structural information may not appear because of limitations in Chempedia's database. Stay tuned for developments in this area.
Ceftobiprole (brand name Zeftera) is a next generation cephalosporin antibiotic with activity against methicillin-resistant Staphylococcus aureus, penicillin-resistant Streptococcus pneumoniae, Pseudomonas aeruginosa, and Enterococci. It was discovered by Basilea Pharmaceutica and was developed by Johnson & Johnson Pharmaceutical Research and Development. It has been shown to be statistically non-inferior to the combination of vancomycin and ceftazidime for the treatment of skin and soft tissue infections.
4 edits since May 19, 2008. Last edited Jul 09, 2008 by Carlo Banez (49).
This Compound Monograph is licensed under the GNU Free Documentation License and uses material from the Wikipedia article Ceftobiprole. See this site's terms for details.